T Cell Receptor Genotyping and <i>HOXA/TLX1</i> Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
Frédéric Baleydier(University of Geneva), Elizabeth Macintyre(Inserm), Philippe Gaulard(Inserm), Julie Bergeron(University of Iowa), Stéphane Leprêtre(Normandie Université), Vahid Asnafi(Hôpital Necker-Enfants Malades), Barbara Petit(Centre Hospitalier Universitaire de Limoges), Kheïra Beldjord(Inserm), Anne‐Valérie Decouvelaere(Centre Léon Bérard), Thierry Jo Molina(Hôpital Necker-Enfants Malades), Hervé Dombret(University of London Institute in Paris), Yves Bertrand(Université Claude Bernard Lyon 1), Danielle Canioni(Inserm)
Cited by 49
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k